Assemblée Générale
Yann Duchesne
Martin Deterre
Ling Ling Chea
Malakoff, 18 juin 2024
Déroulé de l'Assemblée Générale Mixte
Malakoff, le 18 juin 2024
- Ouverture de l'assemblée par le Président
- Constitution du bureau
- Annonce du quorum
- Présentation de l'activité au cours de l'exercice clos le 31 décembre 2023
- Présentation des comptes de l'exercice clos le 31 décembre 2023
- Présentation des rapports du commissaire aux comptes
- Présentation des résolutions
- Clôture de l'assemblée
2 © 2024 Theraclion
Management
Présentation de l'activité
Martin Deterre
LAST 12 MONTHS ACHIEVEMENTS
ON THE 3 STRATEGIC AXES
US Access
FDA feasibility study: Success, 95% efficacy
-
FDA pivotal study:
o Started on time in Oct 23
o Currently on time for last treatment by mid-2024
o Follow-upper plan
China Access
- First class Chinese strategic partner chosen (Furui)
- Partnership framed
- JV structured, team built up
- 1st prototype manufacturing ongoing
Product dev. in EU
- 2500+ treatments
- Commercial relationships with KOL steady
- Tier-1sites at 100 or 150 treatments per year already
- Publication out with 98%+ efficacy
- KOL presentations
2023 : 12 events, 10 speakers,
7 countries
2024 YTD : 14 events, 9 speakers, 8 countries
- R&D:
- HD23 version out, in trial
- Strong progress in acoustics, robotics, AI, Reliability ++
4 © Theraclion - Confidential
Management
Présentation de l'activité
Martin Deterre
VARICOSE VEINS: A WIDESPREAD CONDITION
WHAT ARE VARICOSE VEINS?
Varicose veins are swollen, twisted subcutaneous veins of the lower leg
Inadequacy of the valves results in reflux of blood in the veins
ONE IN THREE ADULTS
31% of adults aged 18 to 64 are affected by varicose veins
Source: Austin Vein Specialists
Source: Maurins et al., 2008
6 | © Theraclion - Confidential |
SONOVEIN®, A NEW ROBOTIC SOLUTION
Robotic treatment head | ||
with in-line visualization | ||
Robotized | ||
head | ||
Consumable: | ||
Real-time | Cooling and coupling | |
Technology (through | ||
ultrasound | Epack ) | |
visualization and | ||
control | Ultrasound imaging probe | |
Présentation avec multimédia avec un remplissage uni | Epack | |
HIFU transducer | ||
Millimetric treatment accuracy |
Video link
INTELLECTUAL PROPERTY
Patents : 164 granted, 211 filed, 30 families in HIFU procedure safety & efficacy, system design and application
8 | © Theraclion - Confidential |
VARICOSE VEINS: A MULTIBILLION $ MARKET POTENTIAL
ALIGNED WITH CURRENT MARKET TRENDS
$13B
Current medical costs for varicose vein treatments worldwide
5M+
Annual addressable procedures
Up to 50%
Sonovein device cost per procedure
vs:
- Stripping: 1-2%
- Endovenous: 10-15%
SIGNIFICANT GROWTH
DRIVERS AND OPPORTUNITIES
-
6,5% annual growth in varicose
veins patients driven by
Age Obesity Lifestyle
-
54% of undiagnosed patients in
industrialized countries - Largely unmet medical need in
emerging countries + China
- 50% of people afraid of surgery
untapped patient pool for
Sonovein
9 | Sources: 1) Millenium studies US 2015-EU 2020 2) Vuylsteke 2015 , Eur J Vasc Endovasc Surg (2015) 49, 432e439 3) Abate, International Journal of Surgery Open 25 (2020) 6e16 | © Theraclion - Confidential |
4) Theraclion estimations | ||
NEW BUSINESS MODEL, PAY-PER-USE
RECURRING REVENUES YEAR ON YEAR VERSUS 1-OFF REVENUES
DIRECT SALES* | PAY-PER-USE | |
Capital equipment | Paying consumables | |
+ | ||
only | ||
Consumables | ||
+ | (w/ monthly min. quantity) | OUR CONSUMABLE |
Service | Single-useEPack : | |
ensures cooling and | ||
coupling |
- To medical centers, hospitals, clinics
10 | © Theraclion - Confidential |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Theraclion SA published this content on 20 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 June 2024 10:06:16 UTC.